Conferences Spyre Therapeutics is attending in 2026

LinkedIn spyre.com

Spyre Therapeutics is listed at 2 conferences on Tnuki's calendar in 2026: ACT 2026 (on the program) and ACR Convergence 2026 (exhibiting). Spyre Therapeutics develops antibody-based therapies for inflammatory bowel disease and other chronic immune-mediated conditions. As of Nov 12, 2026.

Show
ConferenceDetailsInvolvementTnuki guide
47th ACT Annual MeetingPharma & CRO nonclinical safety scientistsOfficial site
San Antonio, TX ~1.4k attendees On the programNo booth or sponsorship in the organizer’s published lists Open the guide Search and filter attendees
ACR Convergence 2026Rheumatologists & autoimmune disease researchersOfficial site
Past Orlando, FL ~15k attendees ExhibitorAs published by American College of Rheumatology Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 66 of the 162 conferences on our calendar, so this page shows Spyre Therapeutics’s involvement at those 66 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Find decision makers at Spyre Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!